[HTML][HTML] Cost-Effectiveness analysis of apixaban versus edoxaban in patients with atrial fibrillation for stroke prevention
I Oyagüez, C Suárez, JL López-Sendón… - PharmacoEconomics …, 2020 - Springer
Objective Our objective was to assess the cost effectiveness of apixaban versus edoxaban
in the prevention of stroke and systemic embolism (SE) in patients with atrial fibrillation (AF) …
in the prevention of stroke and systemic embolism (SE) in patients with atrial fibrillation (AF) …
[HTML][HTML] Cost-Effectiveness Analysis of Apixaban Versus Edoxaban in Patients with Atrial Fibrillation for Stroke Prevention
I Oyagüez, C Suárez, JL López-Sendón… - PharmacoEconomics …, 2020 - ncbi.nlm.nih.gov
Objective Our objective was to assess the cost effectiveness of apixaban versus edoxaban
in the prevention of stroke and systemic embolism (SE) in patients with atrial fibrillation (AF) …
in the prevention of stroke and systemic embolism (SE) in patients with atrial fibrillation (AF) …
Cost-Effectiveness Analysis of Apixaban Versus Edoxaban in Patients with Atrial Fibrillation for Stroke Prevention.
I Oyagüez, C Suárez, JL López-Sendón… - Pharmacoeconomics …, 2020 - europepmc.org
Objective Our objective was to assess the cost effectiveness of apixaban versus edoxaban
in the prevention of stroke and systemic embolism (SE) in patients with atrial fibrillation (AF) …
in the prevention of stroke and systemic embolism (SE) in patients with atrial fibrillation (AF) …
[PDF][PDF] Cost‑Effectiveness Analysis of Apixaban Versus Edoxaban in Patients with Atrial Fibrillation for Stroke Prevention
I Oyagüez, C Suárez, JL López‑Sendón… - 2019 - academia.edu
Objective Our objective was to assess the cost effectiveness of apixaban versus edoxaban
in the prevention of stroke and systemic embolism (SE) in patients with atrial fibrillation (AF) …
in the prevention of stroke and systemic embolism (SE) in patients with atrial fibrillation (AF) …
Cost-Effectiveness Analysis of Apixaban Versus Edoxaban in Patients with Atrial Fibrillation for Stroke Prevention
I Oyagüez, C Suárez, JL López-Sendón… - …, 2020 - search.proquest.com
Objective Our objective was to assess the cost effectiveness of apixaban versus edoxaban
in the prevention of stroke and systemic embolism (SE) in patients with atrial fibrillation (AF) …
in the prevention of stroke and systemic embolism (SE) in patients with atrial fibrillation (AF) …
[PDF][PDF] Cost‑Effectiveness Analysis of Apixaban Versus Edoxaban in Patients with Atrial Fibrillation for Stroke Prevention
I Oyagüez, C Suárez, JL López‑Sendón… - 2019 - runa.sergas.es
Objective Our objective was to assess the cost effectiveness of apixaban versus edoxaban
in the prevention of stroke and systemic embolism (SE) in patients with atrial fibrillation (AF) …
in the prevention of stroke and systemic embolism (SE) in patients with atrial fibrillation (AF) …
Cost-Effectiveness Analysis of Apixaban Versus Edoxaban in Patients with Atrial Fibrillation for Stroke Prevention
I Oyagüez, C Suárez… - …, 2020 - pubmed.ncbi.nlm.nih.gov
Objective Our objective was to assess the cost effectiveness of apixaban versus edoxaban
in the prevention of stroke and systemic embolism (SE) in patients with atrial fibrillation (AF) …
in the prevention of stroke and systemic embolism (SE) in patients with atrial fibrillation (AF) …
Cost-Effectiveness Analysis of Apixaban Versus Edoxaban in Patients with Atrial Fibrillation for Stroke Prevention
I Oyagüez, C Suárez… - …, 2020 - econpapers.repec.org
Objective Our objective was to assess the cost effectiveness of apixaban versus edoxaban
in the prevention of stroke and systemic embolism (SE) in patients with atrial fibrillation (AF) …
in the prevention of stroke and systemic embolism (SE) in patients with atrial fibrillation (AF) …
Cost-Effectiveness Analysis of Apixaban Versus Edoxaban in Patients with Atrial Fibrillation for Stroke Prevention.
I Oyagüez, C Suárez, JL López-Sendón… - PharmacoEconomics …, 2020 - go.gale.com
Objective Our objective was to assess the cost effectiveness of apixaban versus edoxaban
in the prevention of stroke and systemic embolism (SE) in patients with atrial fibrillation (AF) …
in the prevention of stroke and systemic embolism (SE) in patients with atrial fibrillation (AF) …
Cost-Effectiveness Analysis of Apixaban Versus Edoxaban in Patients with Atrial Fibrillation for Stroke Prevention
I Oyagüez, C Suárez, JL López-Sendón… - PharmacoEconomics …, 2020 - ideas.repec.org
Objective Our objective was to assess the cost effectiveness of apixaban versus edoxaban
in the prevention of stroke and systemic embolism (SE) in patients with atrial fibrillation (AF) …
in the prevention of stroke and systemic embolism (SE) in patients with atrial fibrillation (AF) …